HUTCHMED (China) Limited (HCM)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$13.34
-3.33%
Mkt Cap $2.49B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$15.37
Range $13.60 – $18.50
Implied Upside
+15.2%
Consensus $15.37 vs current $13.34